Celltrion Healthcare Ranks High in Searches... Stock Price Up 6.64%
Celltrion Healthcare has ranked among the top searched stocks for 9 days in the past month.
As of 2:30 PM on the 13th, Celltrion Healthcare is trading at 110,800 KRW, up 6.64% from the previous day. This marks a 17.25% increase compared to July 31. Celltrion Healthcare is known as the exclusive distributor of Celltrion's biosimilars.
Today, foreigners have net purchased 488,032 shares of Celltrion Healthcare, and institutions have net purchased 84,000 shares, according to provisional data. Over the past 5 days, individual investors have net sold 238,994 shares, while foreigners and institutions have net sold 327,936 shares and net purchased 569,668 shares, respectively.
On August 10, Celltrion Healthcare was highlighted in the market for its "rising trend expected from biosimilar benefits."


※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
Hot Picks Today
As Samsung Falters, Chinese DRAM Surges: CXMT Returns to Profit in Just One Year
- "Most Americans Didn't Want This"... Americans Lose 60 Trillion Won to Soaring Fuel Costs
- Man in His 30s Dies After Assaulting Father and Falling from Yongin Apartment
- Samsung Union Member Sparks Controversy With Telegram Post: "Let's Push KOSPI Down to 5,000"
- "Why Make Things Like This?" Foreign Media Highlights Bizarre Phenomenon Spreading in Korea
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.